Tenax Therapeutics
Price & Volume
Stats
See more52W Range | $4.63-$18.38 |
Market Cap | $71.3M |
Shares Short | 124,196 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.74 |
News
See moreYahoo Finance • 3 months ago
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
Yahoo Finance • 4 months ago
Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72
Yahoo Finance • 4 months ago
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Mr. Christopher T. Giordano |
CFO | Mr. Thomas A. McGauley |
Address | 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
